These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clinical and laboratory findings in 220 children with recurrent abdominal pain. Gijsbers CF; Benninga M; Büller H Acta Paediatr; 2011 Jul; 100(7):1028-32. PubMed ID: 21272071 [TBL] [Abstract][Full Text] [Related]
12. The effects of withdrawing tegaserod treatment in comparison with continuous treatment in irritable bowel syndrome patients with abdominal pain/discomfort, bloating and constipation: a clinical study. Bardhan KD; Forbes A; Marsden CL; Mason T; Short G Aliment Pharmacol Ther; 2004 Jul; 20(2):213-22. PubMed ID: 15233702 [TBL] [Abstract][Full Text] [Related]
13. Abdominal pain impacts quality of life in women with irritable bowel syndrome. Cain KC; Headstrom P; Jarrett ME; Motzer SA; Park H; Burr RL; Surawicz CM; Heitkemper MM Am J Gastroenterol; 2006 Jan; 101(1):124-32. PubMed ID: 16405544 [TBL] [Abstract][Full Text] [Related]
19. [Dynamics of indices of visceral sensitivity in patients with irritable bowel syndrome treated with spasmolytics]. Makarchuk PA Eksp Klin Gastroenterol; 2007; (6):126-9. PubMed ID: 18418922 [No Abstract] [Full Text] [Related]
20. Octatropine methyl bromide and diazepam combination (Valpinax) in patients with irritable bowel syndrome: a multicentre, randomized, placebo-controlled trial. Pace F; Maurano A; Ciacci C; Savarino V; Attili A; Iaquinto G; Magni E; Porro GB Eur Rev Med Pharmacol Sci; 2010 Mar; 14(3):155-62. PubMed ID: 20391952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]